COLLEGE TO CEO SERIES

Are you interested in learning how to become an effective leader?

Do you want to know what it takes to be a C-Suite Executive? 

 

Say hello to the brand new 'College to CEO' Executive Speaker Series'.

Over the next couple months, the College of Engineering is working with high level executives across a range of industries to speak with Spartan Engineers about their journey, mistakes made along the way, and Spartan-to-Spartan advice. Beyond a standard informational / recruitment session, this will provide a platform for you to network with figures in the industry to identify resources that will help you evolve professionally.

 

All of the speaker sessions will be hosted on Mondays at 7:00 pm EST via webinar.

 

Register for the sessions and we will send you the meeting links for the sessions.

Did you miss a previous speaker? Don't worry! We've got the recorded sessions.

Mike Lamach - photo.jpeg

MAR 8 @ 7PM

MICHAEL LAMACH

CEO at Trane Technologies

Michael W. Lamach is Chairman and Chief Executive Officer of Trane Technologies plc, a global climate innovator focused on sustainable solutions for buildings, homes and transportation. Trane Technologies was launched in 2020 upon the completion of a strategic transaction that created two leading companies – Trane Technologies and Ingersoll Rand.

Prior to Trane Technologies, Mike joined Ingersoll Rand in 2004 and served as president of the Trane Commercial business before being named the company’s president and chief operating officer. He was named chief executive officer and elected chairman of the Board of Directors in 2010. In 2019, the company announced a strategic transaction to spin off Ingersoll Rand’s Industrial segment and merge it with Gardner Denver, creating a global Industrial company, retaining the legacy name of Ingersoll Rand. The remaining climate-focused company was renamed Trane Technologies.

Prior to joining Ingersoll Rand, Lamach served in various leadership roles for Johnson Controls over a 17-year tenure, including group vice president and managing director for the European, Asian, South African and South American businesses of Johnson Controls’ Automotive Group.

Mike holds a bachelor’s degree in engineering from Michigan State University and a master’s degree in business administration from Duke University. He is the Chairman of the Board of Directors for the National Association of Manufacturers, and has served as a director for PPG Industries since 2015 and a member of Duke University’s Fuqua School of Business board of visitors since 2013. In 2019, Mike was named one of Harvard Business Review’s top performing CEOs and listed by Forbes among America’s 100 Most Innovative Leaders.

Kevin_Conroy.jpg

APRIL 5 @ 7PM

KEVIN CONROY

CEO, President. and Chairman of the Board at Exact Sciences 

Kevin Conroy is the Chairman and CEO of Exact Sciences. He became CEO 11 years ago and he has been part of a team that transformed Exact Sciences into one of the world’s premier cancer diagnostics companies with more than 4,500 employees.

Mr. Conroy has led Exact Sciences through the development, clinical trial, regulatory approval, and commercialization of its noninvasive colorectal cancer screening test, Cologuard®. This culminated with Cologuard becoming the first medical device or diagnostic to receive simultaneous FDA approval and national Medicare coverage. Since 2014, millions of Americans have used Cologuard to screen for colorectal cancer, the second leading cause of cancer death in the United States.

In 2019, Exact Sciences’ acquisition of Genomic Health, Inc., united two of the industry’s strongest brands, Cologuard and Oncotype DX®, and established the company’s position as the global leader in advanced cancer diagnostics. The global company is working to improve screening, early detection, and treatment guidance throughout the cancer continuum.

Before joining Exact Sciences, Mr. Conroy served as CEO and President of Third Wave Technologies, a molecular diagnostics company that developed a breakthrough cervical cancer screening test before being acquired by Hologic in 2008. Mr. Conroy also held leadership positions at GE Healthcare, a global leader in medical imaging and information technology, and practiced intellectual property law in private practice . Mr. Conroy currently serves as a director of Epizyme, Inc. and Adaptive Biotechnology Corporation. 

 

Mr. Conroy is active in the Wisconsin community. He serves as a director of the Greater Madison Chamber of Commerce and on the University of Wisconsin-Madison Chancellor’s Advisory Council. He has also served as chair of The United Way of Dane County’s 2016 annual campaign and as a board member of Overture Center for the Arts.

 

A native of Flint, Michigan, Mr. Conroy holds a Bachelor of Science degree in electrical engineering from Michigan State University and earned his Juris Doctorate from the University of Michigan Law School.

PREVIOUS SPEAKERS

 
msu-wordmark-green-221x47.png

Call us: (517) 355-5113

Call MSU: (517) 355-1855  | Visit:  msu.edu  | MSU is an affirmative-action, equal-opportunity employer. |  Notice of Nondiscrimination

SPARTANS WILL.   © Michigan State University